Novo Nordisk has launched a competitive bid to acquire Metsera, a biotech company specializing in obesity treatment, aiming to surpass an offer from Pfizer. The bidding war signals increased interest and competition in the obesity-focused biotech sector.
The American Customer Satisfaction Index read 76.1 in August 2026, the same score it held in 2015, so United States customer expectations have held flat for eleven years while complaints hit records and the variable that actually moved was tolerance.
Read More
TLDR: Regulated-industry marketers who build neuromarketing capabilities at pre-launch stage convert compliance...
Read More